M.S. Safarova, M.V. Ezhov (adapted)
Lipoprotein(a) as a cardiovascular risk factor: current status - p. 6

A.S. Galyavitch, L.P. Salahova
Atorvastatin and fatty acids concentration in patients with IHD - p. 18

Yu.I. Ragino, A.M. Chernyavski, Ya.V. Polonskaya, A.M. Volkov, E.V. Kashtanova
Contents of proinflammatory cytokines, chemoattractants and destructive metallopro-teinases in various tipes of unstable atherosclerotic plaques - p. 23

A.V. Maksimenko & A.D. Turashev
Visualization, composition and structure of endothelial glycocalyx - p. 28

D.N. Nozadze, AE Semenova, V.I. Kaminnaya, T.N. Vlasik, IV Sergienko
Lipoprotein-associated phospholipase A2 – a new position in the risk stratification? - p. 41

D.M. Aronov, V.P .Lupanov
Atherosclerosis and coronary heart disease: some aspects of pathogenesis (Review) - p. 48

I.V. Sergienko
The story of statins - p. 57

Current Events of RNA
Expert meeting - p. 67

Download Abstracts